Physician profile
Patrick H Foley
NPI 1285634139
$1,911.90
in general payments reported to CMS, 2019-2025
29 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.30 · 2020: $44.39 · 2021: $15.00 · 2022: $19.51 · 2023: $293 · 2024: $735 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,774.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $278.66 | 2023-2025 | Axonics, Ams 700, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $219.18 | 2023-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $172.31 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $141.87 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $132.68 | 2024-2025 | |
| Procept Biorobotics Corporation | $100.25 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $90.28 | 2024-2025 | Prolaris |
| Janssen Biotech, INC. | $85.58 | 2019-2024 | Erleada, Akeega |
| Abbvie INC. | $75.91 | 2023-2025 | |
| Endo USA, INC. | $71.19 | 2024-2025 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $70.48 | 2025 | Trelstar, Tlando |
| Linvatec Corporation | $46.28 | 2025 | Linvatec Video Accessories, Airseal, Conmed 3dhd Video Systems |
| Astrazeneca Pharmaceuticals Lp | $46.24 | 2024 | Lynparza |
| Intuitive Surgical, INC. | $44.39 | 2020 | |
| Pfizer INC. | $29.51 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $29.19 | 2025 | Xt Cdx |
| Astellas Pharma US INC | $29.15 | 2024 | Xtandi |
| Immunitybio, INC. | $25.65 | 2025 | |
| Blue Earth Diagnostics | $23.72 | 2025 | Posluma |
| Smith+Nephew, INC. | $23.37 | 2025 | Stravix |
| Agiliti Surgical, INC. | $23.03 | 2024 | Soltive Superpulsed Laser, Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Teleflex LLC | $22.72 | 2024 | Urolift |
| Ambu INC. | $21.13 | 2024 | |
| Progenics Pharmaceuticals, INC. | $20.67 | 2025 | |
| Antares Pharma, INC. | $20.56 | 2024 | Xyosted |
| Allergan, INC. | $19.51 | 2022 | |
| Medtronic, INC. | $17.07 | 2025 | Altaviva |
| Endo Pharmaceuticals INC. | $16.32 | 2024 | Xiaflex |
| Coloplast Corp | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Foley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.